Blocking HIF1α activity eliminates hematological cancer stem cells
- PMID: 21474097
- DOI: 10.1016/j.stem.2011.03.006
Blocking HIF1α activity eliminates hematological cancer stem cells
Abstract
Selective targeting of cancer stem cells (CSCs) has the potential to prevent cancer relapse. Wang et al. (2011) report that hypoxia-inducible factor 1α (HIF1α) represses Notch signaling to maintain CSC subsets from lymphoma, and that blocking HIF1α activity eliminates lymphoma and human acute myeloid leukemia (AML) CSCs.
Copyright © 2011 Elsevier Inc. All rights reserved.
Comment on
-
Targeting HIF1α eliminates cancer stem cells in hematological malignancies.Cell Stem Cell. 2011 Apr 8;8(4):399-411. doi: 10.1016/j.stem.2011.02.006. Cell Stem Cell. 2011. PMID: 21474104 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
